The latest global regulatory news, changes and updates affecting biopharma in Asia, including: FDA, Gilead Sciences, Therapeutic Goods Administration, World Health Organization.
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Allarity, Aridis, Astellas, Beigene, Beijing Tide, Biocardia, Canbridge, Claritas, Daiichi Sankyo, Eli Lilly, ERS Genomics, Essa, FCC Horiuchi, Florica, G+FLAS Life Sciences, Generex, Genscript Probio, Graviton, Hitgen, Insilico Medicine, Moderna, Novartis, Pfizer, Pierre Fabre, Puma, Recce, Sunrock, UCB, Uppthera.
The latest global regulatory news, changes and updates affecting biopharma in Asia, including: Indoco Remedies, Takeda, Therapeutic Goods Administration, Torrent, U.S. Court of Appeals for the Federal Circuit.
New and updated preclinical and clinical data presented by biopharma firms at the American Society of Clinical Oncology Genitourinary Cancers Symposium, including Astellas, Eisai, Merck, Seagen.